Cephasonics, a technology-innovation leader with a game-changing embedded-ultrasound platform, and Orcasonix, an innovative ultrasound company specializing in imaging systems with depth-independent resolution, today disclosed details of the Cephasonics design-in. Orcasonix used the Cephasonics cQuest Cicada™ platform to develop its first prototype imaging system, the Orca™-1, and plans to commercialize the system in 2014 and go to volume production with the just announced cQuest Dragonfly™ system. Orcasonix will be showcasing its new technology in Cephasonics’ booth at RSNA 2013 held here in Chicago from December 1-6. Visitors can also see Cephasonics’ latest technology, including Dragonfly.
According to Mati Shirizly, CEO of Orcasonix, “Cephasonics’ unique business model and flexible cQuest Ultrasound™ hardware/software architecture provided us with a fast way to prove our technology, develop a prototype, and conduct initial clinical trials.” He said that his company’s innovative imaging techniques will dramatically improve the scanning of challenging patients, including general abdominal imaging of obese, overweight patients.
“The Orcasonix team achieved a major breakthrough in ultrasound imaging and we are pleased to partner with them both in demonstrating the unique capabilities of their depth-independent resolution imaging system and supporting their production ramp with our solutions,” said Richard Tobias, CEO of Cephasonics.
Orcasonix developed a new ultrasound imaging system with depth-independent resolution that uses a novel patented approach of generating CT-like images from sound echoes. The technology enables an extremely low cost hardware implementation with a virtually unlimited number of channels at a fraction of the cost of current systems. Signal and image processing is extremely efficient, thus significantly reducing the cost of the ultrasound system’s computer sub-system. The Orca-1 will be the first in a planned family of high-quality, cost-efficient imaging systems.
About Cephasonics
A technology-innovation leader with a game-changing embedded-ultrasound platform, Cephasonics provides a complete range of cQuest™-based technology, systems and components that increase the performance, lower the power and accelerate time-to- market of ultrasound devices. The company’s cQuest Ultrasound API™ software is the catalyst for customer innovations that are spurring a revolution in ultrasound from image-guided procedures to ultrasound as an appliance. Launched with a management buyout in March 2012 and headquartered in Santa Clara, Calif., Cephasonics’ technology, including its AutoFocus™ beamforming technology, has won multiple industry awards for innovation. Additional information about Cephasonics can be found at www.cephasonics.com.
About Orcasonix
An innovative ultrasound imaging company that has developed a new ultrasound-imaging platform with depth-independent resolution, Orcasonix was established in 2011 and is based in Netanya, Israel. Its first product has started clinical trials and others are in early stages of development. Additional information about Orcasonix can be found at www.orcasonix.com.
